Biostage, Inc. Common Stock
BSTG
BSTG was delisted on the 5th of October, 2017.
24 hedge funds and large institutions have $961K invested in Biostage, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 4 closing their positions.
1,100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 1
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
11% less funds holding
Funds holding: 27 → 24 (-3)
38% less capital invested
Capital invested by funds: $1.55M → $961K (-$591K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$334K |
| 2 |
Renaissance Technologies
New York
|
+$202K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$193K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$24.9K |
| 5 |
GAG
GM Advisory Group
Melville,
New York
|
+$8.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$20K |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
-$1K |
| 4 |
Goldman Sachs
New York
|
-$55 |
BSTG Hedge Fund Activity: Q1 2017 in Review
24 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q1 2017, worth a combined $961K — down 38% from $1.55M a quarter earlier.
Fund positioning in BSTG was balanced in Q1 2017: 4 funds opened new positions, 4 closed out, 12 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $334K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $43K sold.
- 24 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q1 2017, down from 27 in Q4 2016.
- Funds reported $961K of Biostage, Inc. Common Stock stock for Q1 2017, down 38% quarter-over-quarter.
- 4 funds opened new Biostage, Inc. Common Stock positions in Q1 2017 and 4 closed out, a net change of 0 holders.
- The largest Biostage, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $334K added.
- The largest Biostage, Inc. Common Stock seller in Q1 2017 was Susquehanna International Group, an estimated $43K sold.
Based on aggregated 13F filings for Q1 2017.